global health

First Opinion By Peter Sands

Why aren’t diseases like HIV and malaria, which still kill millions of people a year, called pandemics?

In the Lab By Erika Check Hayden

Could editing the genomes of bats prevent future coronavirus pandemics? Two scientists think it’s worth a try

First Opinion By Lipi Roy, Reshma Gupta, and Bhavna Lall

India’s doctors — at home and abroad — face Covid’s unrelenting toll

Pharmalot By Ed Silverman

As Covid-19 rages in India, Gilead faces pressure to lower price of drug to treat black fungus in recovering patients

Pharmalot By Ed Silverman

American Medical Association delegates vote to support controversial Covid-19 IP waiver

Pharmalot By Ed Silverman

WTO members agree to step up talks about Covid-19 intellectual property proposals

Pharmalot By Ed Silverman

‘A perilous point’: Global agencies call for $50 billion investment to combat Covid-19

First Opinion By Gagan K. Thapa and Duncan Maru

In ‘vaccine apartheid,’ Nepal is ground zero. It needs U.S. help

Pharmalot By Ed Silverman

Wealthy nations and drug makers offer moves to bridge Covid-19 vaccine divide

First Opinion By Michelle McMurry-Heath

To help solve climate change, look to the biosciences

First Opinion Podcast By Patrick Skerrett

Listen: Chelsea Clinton on fracking, oxygen shortages, and other public health crises

First Opinion By Jonathan Doh

Make drug companies partners — not adversaries — to expand global Covid-19 vaccine access

Pharmalot By Ed Silverman

Most Americans believe Biden is correct to support an IP waiver for Covid-19 vaccines

First Opinion Podcast By Patrick Skerrett

Listen: A veteran health reporter on the brutality of India’s Covid-19 crisis

Pharmalot By Ed Silverman

In Belgium, too many clinical trial sponsors waffle about reporting required results

First Opinion By Dinesh Thakur

India is suffering immensely under the weight of Covid. Now its failures are threatening much of the world

First Opinion By Kalpana Jain

India’s Covid-19 catastrophe reflects years of neglecting its health system

Pharmalot By Ed Silverman

Brazilian senate votes to suspend patents in bid to widen access to Covid-19 vaccines

Pharmalot By Ed Silverman

Will India issue sidestep patents on a pair of pricey — but lifesaving — TB drugs?

First Opinion By Alice Hill and Wayne C. Koff

Climate change and human immunity: invest now or pay more later

Pharmalot By Ed Silverman

Most Americans say they should be vaccinated before the U.S. donates Covid-19 shots elsewhere

Pharmalot By Ed Silverman

WTO head urges movement on controversial Covid-19 vaccine proposal, but objections remain

First Opinion By Ethan Dmitrovsky

Rethinking triage in an era of vaccine nationalism

First Opinion By Ilaria Capua

Looking back at 15 years of sharing viral genomes to forge ahead

First Opinion By Julia Barnes-Weise and Kendall Hoyt

MAPGuide: A tool to help improve health-related public-private partnership agreements